Voloschin A - Search Results

1

Multimodal diagnostic imaging in primary vitreoretinal lymphoma.

Xu LT, Huang Y, Liao A, Anthony CL, Voloschin A, Yeh S. Xu LT, et al. Among authors: voloschin a. Int J Retina Vitreous. 2022 Aug 26;8(1):58. doi: 10.1186/s40942-022-00405-0. Int J Retina Vitreous. 2022. PMID: 36028905 Free PMC article. Review.

2

Cytopathology of Vitreous Specimens in Acute Retinal Necrosis.

Hojjatie SL, Shantha JG, O'Keefe GD, Kraft CS, Voloschin A, Grossniklaus H, Yeh S. Hojjatie SL, et al. Among authors: voloschin a. Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1609-1616. doi: 10.1080/09273948.2021.1922926. Epub 2021 Jul 9. Ocul Immunol Inflamm. 2022. PMID: 34242097 Free PMC article.

3

Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.

Anthony CL, Bavinger JC, Shantha JG, O'Keefe GD, Pearce WA, Voloschin A, Grossniklaus HE, Yeh S. Anthony CL, et al. Among authors: voloschin a. Int J Retina Vitreous. 2021 Dec 4;7(1):72. doi: 10.1186/s40942-021-00346-0. Int J Retina Vitreous. 2021. PMID: 34863313 Free PMC article.

4

Primary CNS natural killer/T-cell lymphoma of the nasal type presenting in a woman: case report and review of the literature.

Prajapati HJ, Vincentelli C, Hwang SN, Voloschin A, Crocker I, Dehkharghani S. Prajapati HJ, et al. Among authors: voloschin a. J Clin Oncol. 2014 Mar 10;32(8):e26-9. doi: 10.1200/JCO.2012.47.6796. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419127 Review. No abstract available.

5

A multicenter, real-world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus.

Dittus C, Grover N, Sethi T, Cohen JB, Voloschin A, Rabadey J, Tan X, Beaven A, Park SI. Dittus C, et al. Among authors: voloschin a. EJHaem. 2022 Jun 2;3(3):734-738. doi: 10.1002/jha2.474. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051081 Free PMC article. No abstract available.

6

Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor.

Gurbani SS, Weinberg BD, Salgado E, Voloschin A, Velazquez Vega JE, Olson JJ, Shu HG, Shim H. Gurbani SS, et al. Among authors: voloschin a. Oxf Med Case Reports. 2020 Mar 30;2020(3):omaa006. doi: 10.1093/omcr/omaa006. eCollection 2020 Mar. Oxf Med Case Reports. 2020. PMID: 32257248 Free PMC article.

7

Using Brain Tumor MRI Structured Reporting to Quantify the Impact of Imaging on Brain Tumor Boards.

Abidi SA, Hoch MJ, Hu R, Sadigh G, Voloschin A, Olson JJ, Shu HG, Neill SG, Weinberg BD. Abidi SA, et al. Among authors: voloschin a. Tomography. 2023 Apr 18;9(2):859-870. doi: 10.3390/tomography9020070. Tomography. 2023. PMID: 37104141 Free PMC article.

8

Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma.

Qian DC, Weinberg BD, Neill SG, Goodman AL, Olson JJ, Voloschin AD, Ramalingam SS, Shu HG. Qian DC, et al. Case Rep Oncol. 2021 Mar 18;14(1):487-492. doi: 10.1159/000514297. eCollection 2021 Jan-Apr. Case Rep Oncol. 2021. PMID: 33976625 Free PMC article.

9

Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma.

Voloschin AD, Betensky R, Wen PY, Hochberg F, Batchelor T. Voloschin AD, et al. J Neurooncol. 2008 Jan;86(2):211-5. doi: 10.1007/s11060-007-9464-6. Epub 2007 Sep 21. J Neurooncol. 2008. PMID: 17896078 Clinical Trial.

10

Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.

Zhong J, Ali AN, Voloschin AD, Liu Y, Curran WJ Jr, Crocker IR, Shu HK. Zhong J, et al. Cancer. 2015 May 1;121(9):1456-62. doi: 10.1002/cncr.29234. Epub 2014 Dec 29. Cancer. 2015. PMID: 25557543 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page